Drugs · acquisition-cost intelligence
ALLEGRA-D
Fexofenadine HCl and Pseudoephedrine HCI· ingredient fexofenadineOther antihistamines for systemic use· FEXOFENADINE HYDROCHLORIDE 60 mg/1; PSEUDOEPHEDRINE HYDROCHLORIDE 120 mg/1
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per EA
$0.42440
NADAC — pharmacy acquisition cost, not a retail/cash price
Acquisition-cost history
Weekly NADAC per EA — the trend nobody else shows. 7 weeks.
2025-12-172026-05-20
Same-ingredient options by acquisition cost
Other fexofenadine products, cheapest acquisition cost first. Per EA — confirm strength/form equivalence before switching.
| Product | NADAC / EA | vs this |
|---|---|---|
| Children Allergy | $0.08776 | −$0.33660 |
| 12HR Allergy Relief | $0.16112 | −$0.26330 |
| 24HR Allergy Relief | $0.24434 | −$0.18010 |
Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.